slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 20,671-20,700
Pages 1,437
Rows per page 30
Arc
20,671-20,700 of 43,093
20
The slide uses stacked bar charts to show segment contributions (GCR vs ODR) and highlights year-over-year percentage changes.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
12
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution1 hit
13
Includes medical imagery of fungal cells and brain infection.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide details the dosing regimens for different cohorts over induction and consolidation phases.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The slide uses a process-flow diagram to present five key clinical findings.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
16
The chart uses a vertical dotted line at 0.2 to denote a clinical efficacy threshold.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
17
Includes n/N counts and specific clinical trial footnotes regarding patient outcomes and data status.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
18
Each patient is represented by a timeline showing rapid decline in fungal load from screening to final visit day.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
19
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
23
The slide uses a map of the US to anchor the revenue projection and a list of four comparable deals to establish market precedent.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Market Sizing1 hit
29
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Team1 hit
08
The slide serves as a title or introductory page for a specific drug candidate.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
26
Includes footnotes regarding anti-dilution provisions and Dong-A license agreement terms.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations Beat · Financials1 hit
06
The slide uses a human anatomy diagram to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to associated clinical side effects.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a list of icons to represent key clinical attributes of the drug candidate.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide uses a Gantt-style timeline to represent drug development stages.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Beat · Market Size1 hit
16
Includes logos of partner firms at the bottom.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Beat · Team1 hit
17
The slide presents real-time financial data for two publicly traded competitors in the regenerative medicine space.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Beat · Competition1 hit
05
The slide uses a standard team bio layout with headshots and titles, followed by a logo grid to establish credibility.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · Team1 hit
06
The slide lists board members followed by a grid of company logos representing their professional backgrounds.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · Team1 hit
03
The slide uses a custom pipeline visualization that maps candidates to specific indications and next milestones.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · Problem1 hit
04
The diagram shows the signaling pathway from extracellular receptor binding to nuclear cytokine induction.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Includes a medical illustration of IV administration and clinical mechanism.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide presents three dot plots comparing Vehicle, MPLA, PHAD, 3D PHAD, and 3D 6-Acyl PHAD treatments.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
08
Includes three dot plots for bacterial clearance (Lung, Spleen, Kidney) and one Kaplan-Meier survival curve.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
09
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
Includes a before-after comparison of medical efficacy and a market growth chart.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a combination of line charts and bar charts to present clinical trial results.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Revelation Biosciences | Investor Presentation Deck | 18 slidesRevelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit